3.22.2.2 html 158 277 1 false 53 0 false 10 false false R1.htm 100000 - Document - Cover Page Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DocumentCoverPage Cover Page Cover 1 false false R2.htm 100010 - Statement - Unaudited Interim Condensed Consolidated Statements of Loss Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfLoss Unaudited Interim Condensed Consolidated Statements of Loss Statements 2 false false R3.htm 100040 - Statement - Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveLoss Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss Statements 3 false false R4.htm 100050 - Statement - Unaudited Interim Condensed Consolidated Balance Sheets Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/StatementUnauditedInterimCondensedConsolidatedBalanceSheets Unaudited Interim Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 100060 - Statement - Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' (Deficit)/Equity Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInShareholdersDeficitequity Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' (Deficit)/Equity Statements 5 false false R6.htm 100070 - Statement - Unaudited Interim Condensed Consolidated Statements of Cash Flows Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows Unaudited Interim Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100080 - Disclosure - General Information, Reorganization and Basis of Presentation Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureGeneralInformationReorganizationAndBasisOfPresentation General Information, Reorganization and Basis of Presentation Notes 7 false false R8.htm 100090 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100100 - Disclosure - Fair Value Estimation Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimation Fair Value Estimation Notes 9 false false R10.htm 100110 - Disclosure - Critical Accounting Estimates and Judgements Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCriticalAccountingEstimatesAndJudgements Critical Accounting Estimates and Judgements Notes 10 false false R11.htm 100120 - Disclosure - Expenses by Nature Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureExpensesByNature Expenses by Nature Notes 11 false false R12.htm 100130 - Disclosure - Employee Benefit Expenses Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureEmployeeBenefitExpenses Employee Benefit Expenses Notes 12 false false R13.htm 100140 - Disclosure - Other Income Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncome1 Other Income Notes 13 false false R14.htm 100150 - Disclosure - Other (Losses)/Gains - Net Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherLossesgainsNet Other (Losses)/Gains - Net Notes 14 false false R15.htm 100160 - Disclosure - Income Taxes Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 15 false false R16.htm 100170 - Disclosure - Loss Per Share Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLossPerShare1 Loss Per Share Notes 16 false false R17.htm 100180 - Disclosure - Property, Plant and Equipment Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment Property, Plant and Equipment Notes 17 false false R18.htm 100190 - Disclosure - Leases Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeases1 Leases Notes 18 false false R19.htm 100200 - Disclosure - Financial Assets at Fair Value Through Comprehensive Income Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFinancialAssetsAtFairValueThroughComprehensiveIncome Financial Assets at Fair Value Through Comprehensive Income Notes 19 false false R20.htm 100210 - Disclosure - Other non-current Assets Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherNoncurrentAssets Other non-current Assets Notes 20 false false R21.htm 100220 - Disclosure - Other Receivables and Prepayments Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherReceivablesAndPrepayments Other Receivables and Prepayments Notes 21 false false R22.htm 100230 - Disclosure - Cash and Cash Equivalents Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCashAndCashEquivalents1 Cash and Cash Equivalents Notes 22 false false R23.htm 100240 - Disclosure - Share Capital Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureShareCapital Share Capital Notes 23 false false R24.htm 100250 - Disclosure - Share-Based Compensation Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensation Share-Based Compensation Notes 24 false false R25.htm 100260 - Disclosure - Other Payables and Accruals Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherPayablesAndAccruals Other Payables and Accruals Notes 25 false false R26.htm 100270 - Disclosure - Financial Instruments with Preferred Rights Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRights Financial Instruments with Preferred Rights Notes 26 false false R27.htm 100280 - Disclosure - Cash Flow Information Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCashFlowInformation Cash Flow Information Notes 27 false false R28.htm 100290 - Disclosure - Commitments Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCommitments Commitments Notes 28 false false R29.htm 100300 - Disclosure - Related Party Transactions Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactions Related Party Transactions Notes 29 false false R30.htm 100310 - Disclosure - Events After the Reporting Period Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureEventsAfterReportingPeriod Events After the Reporting Period Notes 30 false false R31.htm 100330 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 31 false false R32.htm 100360 - Disclosure - Fair Value Estimation (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimationTables Fair Value Estimation (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimation 32 false false R33.htm 100370 - Disclosure - Expenses by Nature (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureExpensesByNatureTables Expenses by Nature (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureExpensesByNature 33 false false R34.htm 100380 - Disclosure - Employee Benefit Expenses (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureEmployeeBenefitExpensesTables Employee Benefit Expenses (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureEmployeeBenefitExpenses 34 false false R35.htm 100390 - Disclosure - Other Income (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncomeTables Other Income (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncome1 35 false false R36.htm 100400 - Disclosure - Other (Losses)/Gains - Net (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherLossesgainsNetTables Other (Losses)/Gains - Net (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncome1 36 false false R37.htm 100430 - Disclosure - Loss Per Share (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLossPerShareTables Loss Per Share (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLossPerShare1 37 false false R38.htm 100440 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipment 38 false false R39.htm 100450 - Disclosure - Leases (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeases1 39 false false R40.htm 100460 - Disclosure - Financial Assets at Fair Value Through Comprehensive Income (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFinancialAssetsAtFairValueThroughComprehensiveIncomeTables Financial Assets at Fair Value Through Comprehensive Income (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFinancialAssetsAtFairValueThroughComprehensiveIncome 40 false false R41.htm 100470 - Disclosure - Other non-current Assets (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherNoncurrentAssetsTables Other non-current Assets (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherNoncurrentAssets 41 false false R42.htm 100480 - Disclosure - Other Receivables and Prepayments (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherReceivablesAndPrepaymentsTables Other Receivables and Prepayments (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherReceivablesAndPrepayments 42 false false R43.htm 100490 - Disclosure - Cash and Cash Equivalents (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCashAndCashEquivalentsTables Cash and Cash Equivalents (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCashAndCashEquivalents1 43 false false R44.htm 100500 - Disclosure - Share Capital (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureShareCapitalTables Share Capital (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureShareCapital 44 false false R45.htm 100510 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationTables Share-Based Compensation (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensation 45 false false R46.htm 100520 - Disclosure - Other Payables and Accruals (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherPayablesAndAccrualsTables Other Payables and Accruals (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherPayablesAndAccruals 46 false false R47.htm 100530 - Disclosure - Financial Instruments with Preferred Rights (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRightsTables Financial Instruments with Preferred Rights (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRights 47 false false R48.htm 100540 - Disclosure - Cash Flow Information (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCashFlowInformationTables Cash Flow Information (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCashFlowInformation 48 false false R49.htm 100550 - Disclosure - Related Party Transactions (Tables) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactions 49 false false R50.htm 100560 - Disclosure - General Information, Reorganization and Basis of Presentation - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureGeneralInformationReorganizationAndBasisOfPresentationAdditionalInformationDetails General Information, Reorganization and Basis of Presentation - Additional Information (Details) Details 50 false false R51.htm 100570 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 51 false false R52.htm 100580 - Disclosure - Fair Value Estimation - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimationAdditionalInformationDetails Fair Value Estimation - Additional Information (Details) Details 52 false false R53.htm 100590 - Disclosure - Fair Value Estimation - Summary of Financial Instruments Carried at Fair Value by Level of Inputs to Valuation Techniques (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimationSummaryOfFinancialInstrumentsCarriedAtFairValueByLevelOfInputsToValuationTechniquesDetails Fair Value Estimation - Summary of Financial Instruments Carried at Fair Value by Level of Inputs to Valuation Techniques (Details) Details 53 false false R54.htm 100600 - Disclosure - Fair Value Estimation - Summary of Changes in Financial Instruments of Short-term and Long-term Investments (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimationSummaryOfChangesInFinancialInstrumentsOfShorttermAndLongtermInvestmentsDetails Fair Value Estimation - Summary of Changes in Financial Instruments of Short-term and Long-term Investments (Details) Details 54 false false R55.htm 100620 - Disclosure - Fair Value Estimation - Summary of Changes in Level 3 Instruments of Short-term Investment (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFairValueEstimationSummaryOfChangesInLevel3InstrumentsOfShorttermInvestmentDetails Fair Value Estimation - Summary of Changes in Level 3 Instruments of Short-term Investment (Details) Details 55 false false R56.htm 100630 - Disclosure - Expenses by Nature - Summary of Expenses by Nature (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureExpensesByNatureSummaryOfExpensesByNatureDetails Expenses by Nature - Summary of Expenses by Nature (Details) Details 56 false false R57.htm 100640 - Disclosure - Employee Benefit Expenses - Schedule of Employee Benefit Expenses (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureEmployeeBenefitExpensesScheduleOfEmployeeBenefitExpensesDetails Employee Benefit Expenses - Schedule of Employee Benefit Expenses (Details) Details 57 false false R58.htm 100650 - Disclosure - Employee Benefit Expenses - Schedule of Employee Benefit Expenses Included in Consolidated Statements of Loss (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureEmployeeBenefitExpensesScheduleOfEmployeeBenefitExpensesIncludedInConsolidatedStatementsOfLossDetails Employee Benefit Expenses - Schedule of Employee Benefit Expenses Included in Consolidated Statements of Loss (Details) Details 58 false false R59.htm 100660 - Disclosure - Other Income - Summary of Other Income (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncomeSummaryOfOtherIncomeDetails Other Income - Summary of Other Income (Details) Details 59 false false R60.htm 100670 - Disclosure - Other Income - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncomeAdditionalInformationDetails Other Income - Additional Information (Details) Details 60 false false R61.htm 100680 - Disclosure - Other (Losses)/Gains - Net - Schedule of Other (Losses)/Gains - Net (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherLossesgainsNetScheduleOfOtherLossesgainsNetDetails Other (Losses)/Gains - Net - Schedule of Other (Losses)/Gains - Net (Details) Details http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncomeTables 61 false false R62.htm 100690 - Disclosure - Other (Losses)/Gains - Net - Schedule of Other (Losses)/Gains - Net (Parenthetical) (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherLossesgainsNetScheduleOfOtherLossesgainsNetParentheticalDetails Other (Losses)/Gains - Net - Schedule of Other (Losses)/Gains - Net (Parenthetical) (Details) Details http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherIncomeTables 62 false false R63.htm 100700 - Disclosure - Income taxes - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails Income taxes - Additional Information (Details) Details 63 false false R64.htm 100710 - Disclosure - Loss Per Share - Schedule of Net Basic Loss Per Share (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLossPerShareScheduleOfNetBasicLossPerShareDetails Loss Per Share - Schedule of Net Basic Loss Per Share (Details) Details 64 false false R65.htm 100720 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetails Property, Plant and Equipment - Summary of Property, Plant and Equipment (Details) Details 65 false false R66.htm 100730 - Disclosure - Leases - Schedule of Amounts Recognized in Consolidated Balance Sheets as Right-of-use Assets (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfAmountsRecognizedInConsolidatedBalanceSheetsAsRightofuseAssetsDetails Leases - Schedule of Amounts Recognized in Consolidated Balance Sheets as Right-of-use Assets (Details) Details 66 false false R67.htm 100740 - Disclosure - Leases - Schedule of Amounts Recognized in Consolidated Balance Sheets as Lease Liability (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfAmountsRecognizedInConsolidatedBalanceSheetsAsLeaseLiabilityDetails Leases - Schedule of Amounts Recognized in Consolidated Balance Sheets as Lease Liability (Details) Details 67 false false R68.htm 100750 - Disclosure - Leases - Schedule of Amounts Recognized in Consolidated Statements of Loss in Addition to Depreciation (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfAmountsRecognizedInConsolidatedStatementsOfLossInAdditionToDepreciationDetails Leases - Schedule of Amounts Recognized in Consolidated Statements of Loss in Addition to Depreciation (Details) Details 68 false false R69.htm 100760 - Disclosure - Leases - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 69 false false R70.htm 100770 - Disclosure - Financial Assets at Fair Value Through Comprehensive Income - Schedule of Financial Assets at Fair Value Through Comprehensive Income of Debt Securities (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFinancialAssetsAtFairValueThroughComprehensiveIncomeScheduleOfFinancialAssetsAtFairValueThroughComprehensiveIncomeOfDebtSecurit Financial Assets at Fair Value Through Comprehensive Income - Schedule of Financial Assets at Fair Value Through Comprehensive Income of Debt Securities (Details) Details 70 false false R71.htm 100780 - Disclosure - Financial Assets at Fair Value Through Comprehensive Income - Schedule of Debt Investments Recognized in Profit or Loss and Other Comprehensive Income Explanatory (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureFinancialAssetsAtFairValueThroughComprehensiveIncomeScheduleOfDebtInvestmentsRecognizedInProfitOrLossAndOtherComprehensiveIncom Financial Assets at Fair Value Through Comprehensive Income - Schedule of Debt Investments Recognized in Profit or Loss and Other Comprehensive Income Explanatory (Details) Details 71 false false R72.htm 100800 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherNoncurrentAssetsScheduleOfOtherNoncurrentAssetsDetails Other non-current Assets - Schedule of Other Non-current Assets (Details) Details 72 false false R73.htm 100810 - Disclosure - Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherNoncurrentAssetsScheduleOfOtherNoncurrentAssetsParentheticalDetails Other non-current Assets - Schedule of Other Non-current Assets (Parenthetical) (Details) Details 73 false false R74.htm 100820 - Disclosure - Other Receivables and Prepayments - Schedule of Other Receivables and Prepayments (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherReceivablesAndPrepaymentsScheduleOfOtherReceivablesAndPrepaymentsDetails Other Receivables and Prepayments - Schedule of Other Receivables and Prepayments (Details) Details 74 false false R75.htm 100830 - Disclosure - Other Receivables and Prepayments - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureOtherReceivablesAndPrepaymentsAdditionalInformationDetails Other Receivables and Prepayments - Additional Information (Details) Details 75 false false R76.htm 100840 - Disclosure - Cash and Cash Equivalents - Schedule of Cash And Cash Equivalents (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails Cash and Cash Equivalents - Schedule of Cash And Cash Equivalents (Details) Details 76 false false R77.htm 100850 - Disclosure - Cash and Cash Equivalents - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureCashAndCashEquivalentsAdditionalInformationDetails Cash and Cash Equivalents - Additional Information (Details) Details 77 false false R78.htm 100860 - Disclosure - Share Capital - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureShareCapitalAdditionalInformationDetails Share Capital - Additional Information (Details) Details 78 false false R79.htm 100870 - Disclosure - Share Capital - Schedule of Share Capital and Share Premium (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureShareCapitalScheduleOfShareCapitalAndSharePremiumDetails Share Capital - Schedule of Share Capital and Share Premium (Details) Details 79 false false R80.htm 100880 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 80 false false R81.htm 100890 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfOptionsOutstandingDetails Share-Based Compensation - Summary of Options Outstanding (Details) Details 81 false false R82.htm 100900 - Disclosure - Share-Based Compensation - Summary of Key Assumptions for Options Granted (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfKeyAssumptionsForOptionsGrantedDetails Share-Based Compensation - Summary of Key Assumptions for Options Granted (Details) Details 82 false false R83.htm 100910 - Disclosure - Share-Based Compensation - Summary of Key Assumptions for Options Granted (Parenthetical) (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfKeyAssumptionsForOptionsGrantedParentheticalDetails Share-Based Compensation - Summary of Key Assumptions for Options Granted (Parenthetical) (Details) Details 83 false false R84.htm 100920 - Disclosure - Share-Based Compensation - Summary of Share-Based Compensation Expenses (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfSharebasedCompensationExpensesDetails Share-Based Compensation - Summary of Share-Based Compensation Expenses (Details) Details 84 false false R85.htm 100930 - Disclosure - Other Payables and Accruals - Schedule of Other Payables and Accruals (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureOtherPayablesAndAccrualsScheduleOfOtherPayablesAndAccrualsDetails Other Payables and Accruals - Schedule of Other Payables and Accruals (Details) Details 85 false false R86.htm 100940 - Disclosure - Financial Instruments with Preferred Rights - Summary of Series of Financings by Issuing Preferred Shares (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRightsSummaryOfSeriesOfFinancingsByIssuingPreferredSharesDetails Financial Instruments with Preferred Rights - Summary of Series of Financings by Issuing Preferred Shares (Details) Details 86 false false R87.htm 100950 - Disclosure - Financial Instruments with Preferred Rights - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRightsAdditionalInformationDetails Financial Instruments with Preferred Rights - Additional Information (Details) Details 87 false false R88.htm 100960 - Disclosure - Financial Instruments with Preferred Rights - Movements of Financial Instruments with Preferred Rights (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRightsMovementsOfFinancialInstrumentsWithPreferredRightsDetails Financial Instruments with Preferred Rights - Movements of Financial Instruments with Preferred Rights (Details) Details 88 false false R89.htm 100970 - Disclosure - Financial Instruments with Preferred Rights - Key Valuation Assumptions Used to Determine Fair Value of Financial Instruments with Preferred Rights (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureFinancialInstrumentsWithPreferredRightsKeyValuationAssumptionsUsedToDetermineFairValueOfFinancialInstrumentsWithPreferredRightsDetails Financial Instruments with Preferred Rights - Key Valuation Assumptions Used to Determine Fair Value of Financial Instruments with Preferred Rights (Details) Details 89 false false R90.htm 100980 - Disclosure - Cash Flow Information - Summary of Cash Used in Operations (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCashFlowInformationSummaryOfCashUsedInOperationsDetails Cash Flow Information - Summary of Cash Used in Operations (Details) Details 90 false false R91.htm 100990 - Disclosure - Commitments - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAdditionalInformationDetails Commitments - Additional Information (Details) Details 91 false false R92.htm 101000 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 92 false false R93.htm 101010 - Disclosure - Related Party Transactions - Summary of Key Management Personnel Compensation (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsSummaryOfKeyManagementPersonnelCompensationDetails Related Party Transactions - Summary of Key Management Personnel Compensation (Details) Details 93 false false R94.htm 101020 - Disclosure - Related Party Transactions - Summary of Key Management Personnel Compensation (Parenthetical) (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureRelatedPartyTransactionsSummaryOfKeyManagementPersonnelCompensationParentheticalDetails Related Party Transactions - Summary of Key Management Personnel Compensation (Parenthetical) (Details) Details 94 false false R95.htm 101030 - Disclosure - Events After the Reporting Period - Additional Information (Details) Sheet http://www.connectbiopharm.com/20220630/taxonomy/role/DisclosureEventsAfterTheReportingPeriodAdditionalInformationDetails Events After the Reporting Period - Additional Information (Details) Details 95 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: cntb:NumberOfSharesRepresentedByOneDepositaryShares, ifrs-full:ProfitLossFromOperatingActivities - cntb-20220630.htm 8 cntb-20220630.htm cntb-20220630.xsd cntb-20220630_cal.xml cntb-20220630_def.xml cntb-20220630_lab.xml cntb-20220630_pre.xml cntb-ex99_1.htm http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true